Ticker
BCYCCompany Name
BICYCLE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -240.81M | -1248.97% | $ 19.28M |
3/31/2025 | $ -200.61M | -779.93% | $ 25.72M |
12/31/2024 | $ -164.89M | -467.45% | $ 35.27M |
9/30/2024 | $ -160.02M | -433.67% | $ 36.9M |
6/30/2024 | $ -153.09M | -386.86% | $ 39.57M |
3/31/2024 | $ -156.51M | -376.15% | $ 41.61M |
12/31/2023 | $ -169.4M | -627.96% | $ 26.98M |
9/30/2023 | $ -151.28M | -609.26% | $ 24.83M |
6/30/2023 | $ -132.66M | -589.13% | $ 22.52M |
3/31/2023 | $ -117.78M | -759.93% | $ 15.5M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for BICYCLE THERAPEUTICS PLC is calculated as follows: EBITDA [ $ -37.57M ] / Revenues [ $ 11.82M ]
(=) EBITDA % [ -317.79% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |